Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Duda

Showing results (201-210 of 338) with videos related to

Pageof 34
Sort By:
Nature Communications|February 10, 2022
Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapyYuling Xiao, Jiang Chen, Hui Zhou, et al.
Clinical Ovarian Cancer and Other Gynecologic Malignancies|August 12, 2011
Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian CarcinomaNeil S Horowitz, Richard T Penson, Dan G Duda, et al.
United European Gastroenterology Journal|November 23, 2017
Use of inhibitors of the renin-angiotensin system is associated with longer survival in patients with hepatocellular carcinomaMatthias Pinter, Arndt Weinmann, Marcus-Alexander Wörns, et al.
Przeglad Lekarski|January 1, 1982
[Epidemiology and diagnosis of hypertension in the Upper Silesia industrial region. III. Serum cholesterol concentration in hypertensive and normotensive persons in the industrial and non-industrial regions]F Kokot, J Kuska, R Baczyński, et al.
Przeglad Lekarski|September 1, 1982
[Epidemiology and diagnosis of hypertension in the Upper-Silesian industrial region. IV. Serum uric acid level in normotensive and hypertensive persons in the industrialized and non-industrialized regions]F Kokot, J Kuska, R Baczyński, et al.
Pancreas|April 16, 2004
The role of chromosome 18 abnormalities in the progression of pancreatic adenocarcinomaMakoto Sunamura, Liviu P Lefter, Dan G Duda, et al.
Research Square|May 5, 2025
Inhibiting B-cell-mediated Immunosuppression to Enhance the Immunotherapy Efficacy in Hepatocellular CarcinomaXin Liu, Zelong Liu, Tatsuya Kobayashi, et al.
Przeglad Lekarski|January 1, 1982
[Epidemiology and diagnosis of hypertension in the Upper Silesian industrial region. II. Evaluation of the effectiveness of antihypertensive treatment in the industrialized and non-industrialized regions during the years 1977-1979]F Kokot, J Kuska, R Baczyński, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|November 1, 1995
[The pharmacokinetics of propranolol and its conjugated metabolites in patients with chronic ischemic heart disease and arterial hypertension with a one-time and course intake of the drug]V G Belolipetskaia, D S Rumiantsev, V K Piotrovskiĭ, et al.
Cancers|May 24, 2020
Potential Circulating Biomarkers of Recurrence after Hepatic Resection or Liver Transplantation in Hepatocellular Carcinoma PatientsDan G Duda, Simona O Dima, Dana Cucu, et al.
Pageof 34

Showing results (201-210 of 338) with videos related to

Sort By:
Pageof 34
Nature Communications|February 10, 2022
Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapyYuling Xiao, Jiang Chen, Hui Zhou, et al.
Clinical Ovarian Cancer and Other Gynecologic Malignancies|August 12, 2011
Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian CarcinomaNeil S Horowitz, Richard T Penson, Dan G Duda, et al.
United European Gastroenterology Journal|November 23, 2017
Use of inhibitors of the renin-angiotensin system is associated with longer survival in patients with hepatocellular carcinomaMatthias Pinter, Arndt Weinmann, Marcus-Alexander Wörns, et al.
Przeglad Lekarski|January 1, 1982
[Epidemiology and diagnosis of hypertension in the Upper Silesia industrial region. III. Serum cholesterol concentration in hypertensive and normotensive persons in the industrial and non-industrial regions]F Kokot, J Kuska, R Baczyński, et al.
Przeglad Lekarski|September 1, 1982
[Epidemiology and diagnosis of hypertension in the Upper-Silesian industrial region. IV. Serum uric acid level in normotensive and hypertensive persons in the industrialized and non-industrialized regions]F Kokot, J Kuska, R Baczyński, et al.
Pancreas|April 16, 2004
The role of chromosome 18 abnormalities in the progression of pancreatic adenocarcinomaMakoto Sunamura, Liviu P Lefter, Dan G Duda, et al.
Research Square|May 5, 2025
Inhibiting B-cell-mediated Immunosuppression to Enhance the Immunotherapy Efficacy in Hepatocellular CarcinomaXin Liu, Zelong Liu, Tatsuya Kobayashi, et al.
Przeglad Lekarski|January 1, 1982
[Epidemiology and diagnosis of hypertension in the Upper Silesian industrial region. II. Evaluation of the effectiveness of antihypertensive treatment in the industrialized and non-industrialized regions during the years 1977-1979]F Kokot, J Kuska, R Baczyński, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|November 1, 1995
[The pharmacokinetics of propranolol and its conjugated metabolites in patients with chronic ischemic heart disease and arterial hypertension with a one-time and course intake of the drug]V G Belolipetskaia, D S Rumiantsev, V K Piotrovskiĭ, et al.
Cancers|May 24, 2020
Potential Circulating Biomarkers of Recurrence after Hepatic Resection or Liver Transplantation in Hepatocellular Carcinoma PatientsDan G Duda, Simona O Dima, Dana Cucu, et al.
Pageof 34